Market Overview

UPDATE: Goldman Sachs Downgrades Intuitive Surgical on Disappointing 2Q2013 Results

Related ISRG
Canaccord On Intuitive Surgical Following Earnings: 'Stay Buyers'
12 Stocks You Should Be Watching Today

In a report published on Tuesday, Goldman Sachs analyst David H. Roman downgraded Intuitive Surgical (NASDAQ: IRSG) to Neutral and lowered the price target to $500 from $676.

In the report, Goldman Sachs noted, "While procedure volumes were somewhat better than most had feared (no material change in growth vs. Q1), the US capital equipment business looks to be facing material incremental headwinds".

Intuitive Surgical closed on Monday at $500.08.

Latest Ratings for ISRG

Jan 2017Evercore ISI GroupDowngradesBuyHold
Oct 2016Wells FargoInitiates Coverage OnOutperform
Aug 2016Raymond JamesInitiates Coverage onOutperform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David H. Roman Goldman SachsAnalyst Color Downgrades Analyst Ratings


Related Articles (ISRG)

View Comments and Join the Discussion!